Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WENZHOU MEDICAL UNIV
- Publication Date
- 2007-03-28
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the preparation of eucalyptane-type sesquiterpene derivatives 1β-Hydroxyililic acid (1β-Hydroxyililic acid), i.e. 1β-hydroxyl-5αH-eucalyptane-11(13)-ene-12-acid, in the preparation of medicines for treating hepatitis B virus infection medicinal use in. technical background
[0002] Hepatitis B is an infectious disease caused by the hepatitis B virus. Transmitted through blood and body fluids, with a chronic carrier state. The disease is widely prevalent in my country, and the infection rate among the population is high, and the infection rate reaches more than 35% in some areas. According to relevant data, the number of patients who tested positive for hepatitis has reached 189 million, while the number of people who should see a doctor but have not (carriers) is nearly 400 million. It is one of the most serious infectious diseases currently endangering people's health. The clinical manifestations of hepatitis B are diverse...